A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus.

https://ift.tt/2Bki5pi

A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. https://ift.tt/2Bki5pi See the source article by following the link below https://ift.tt/2ZKGgGC